SJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, Blastic Phase Chronic Myelogenous Leukemia, or Chronic Lymphocytic Leukemia

计划入组 25 人 · 首次发布于 2006 年 3 月 13 日

AHN-12 Biodistribution in Advanced Leukemia

计划入组 8 人 · 首次发布于 2010 年 9 月 22 日

Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation

计划入组 6 人 · 首次发布于 2003 年 3 月 28 日

Retpamir (Advanced Medical Projects)

177Lu/225Ac labeled alphavbeta3-integrin targeting peptidomimetics (Advanced Innovative Partners)

ALKS-2680

JAPAN ADULT LEUKEMIA STUDY GROUP

Japan

ADVANCED BIONICS

France

ADVANCED SCANNERS, INC.

United States

FDA Approves Syndax's Revuforj, a Novel Menin Inhibitor, for KMT2A-Rearranged Leukemia

Nurix Therapeutics' NX-5948 Receives FDA Fast Track for Waldenstrom's Macroglobulinemia

FDA Approves Revumenib for Relapsed or Refractory KMT2A-Rearranged Acute Leukemia